These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28993300)

  • 1. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
    Ennassiri W; Jaouhari S; Sabouni R; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
    J Glob Antimicrob Resist; 2018 Mar; 12():197-201. PubMed ID: 28993300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
    Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
    Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
    PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.
    Jin J; Zhang Y; Fan X; Diao N; Shao L; Wang F; Hu P; Wang S; Weng X; Zhang W
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):521-6. PubMed ID: 22325117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the GenoType
    Stephen S; Muzhizhizhi D; Dhibi N; Chidemo T; Samaneka W; Matubu TA; Hakim JG; Chirenje ZM
    Int J Mycobacteriol; 2019; 8(1):83-88. PubMed ID: 30860184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Diagn Microbiol Infect Dis; 2015 May; 82(1):49-53. PubMed ID: 25749461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
    Benaissa E; Benlahlou Y; Bssaibis F; Maleb A; Elouennass M
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of discrepant results between the Genotype
    Jo KW; Yeo Y; Sung H; Kim MN; Shim TS
    Respir Med; 2017 Jan; 122():12-17. PubMed ID: 27993285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Aono A; Yamada H; Sugamoto T; Nishiyama H; Mitarai S
    Kekkaku; 2011 Jul; 86(7):697-702. PubMed ID: 21922778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
    Yıldırım E; Uzun M
    Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level.
    Kebede A; Demisse D; Assefa M; Getachew Z; Yenew B; Tedla Y; Ameni G
    BMC Res Notes; 2017 Dec; 10(1):661. PubMed ID: 29191227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capacity of Abbott RealTi
    Hofmann-Thiel S; Molodtsov N; Duffner C; Kadyrov A; Kalmambetova G; Kabirov O; Rajabov A; Parpieva N; Sayfutdinov Z; Vogel M; Vogel H; Antonenka U; Hoffmann H
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):458-464. PubMed ID: 31064625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.